Dihydroergotamine Mesylate is a Intramuscular; Intravenous; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Cenexi Hsc. The primary component is Dihydroergotamine Mesylate.
| Product ID | 82454-0411_d460013a-0fb7-e3ae-e053-2a95a90a1f0f |
| NDC | 82454-0411 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Dihydroergotamine Mesylate |
| Generic Name | Dihydroergotamine Mesylate |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Marketing Start Date | 2020-04-14 |
| Marketing Category | ANDA / |
| Application Number | ANDA212046 |
| Labeler Name | CENEXI HSC |
| Substance Name | DIHYDROERGOTAMINE MESYLATE |
| Active Ingredient Strength | 1 mg/mL |
| Pharm Classes | Ergotamines [CS],Ergotamine Derivative [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2020-04-14 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0143-9273 | Dihydroergotamine Mesylate | Dihydroergotamine Mesylate |
| 0574-0850 | Dihydroergotamine Mesylate | Dihydroergotamine Mesylate |
| 0574-0851 | dihydroergotamine mesylate | dihydroergotamine mesylate |
| 24201-463 | Dihydroergotamine Mesylate | Dihydroergotamine Mesylate |
| 25021-609 | dihydroergotamine mesylate | dihydroergotamine mesylate |
| 61990-0411 | Dihydroergotamine Mesylate | Dihydroergotamine Mesylate |
| 68682-357 | Dihydroergotamine Mesylate | dihydroergotamine mesylate |
| 69238-1606 | Dihydroergotamine Mesylate | Dihydroergotamine |
| 81284-411 | Dihydroergotamine Mesylate | Dihydroergotamine Mesylate |
| 82454-0411 | Dihydroergotamine Mesylate | Dihydroergotamine Mesylate |
| 66490-041 | D.H.E. 45 | Dihydroergotamine Mesylate |
| 70529-030 | Dromelate | Dihydroergotamine Mesylate |
| 0187-0245 | Migranal | dihydroergotamine mesylate |
| 77530-725 | Trudhesa | Dihydroergotamine mesylate |